And so are some other blogs on our health and wellness channel…

Other Health & Wellness Channel blogs in the top 100 are:

# 6 – Healthbolt
# 19 – Autism Vox
# 52 – Lively Women
# 57 – Eating Fabulous
#61 – Mental Health Notes
# 80 – Genetics and Health
# 83 – A Hearty Life
# 91 – Diabetes Notes

Thanks Alicia

Post from: Blisstree

Yee ha! We are on the top 100 at edrugsearch.com- Corrected

Merck hopes the combination version will make it easier for those diabetics to control their blood sugar levels.

This comes only 5 months after the drug Januvia was approved by the federal drug administration. Januvia is the first of its type on the market.

JANUVIA is a once-daily pill that helps lower blood sugar levels in people with type 2 diabetes, along with diet and exercise. It’s a type of prescription diabetes medicine called a DPP-4 inhibitor (blocker). DPP-4 blockers enhance the body’s own ability to keep blood sugar levels balanced.

It is a no brainer for Merck and Co.. More than a third of all diabetic prescriptions are for metformin. Over 90% of patients with diabetes are type 2 diabetics. You do the math! And with each pill costing $3-$5, I venture to say Merck will make out just fine.

The medicine will help Merck compete for a bigger share of the $17 billion market for diabetes treatments, with Januvia and Janumet expected to have more than $2 billion in combined annual sales by 2010, analysts said

How will prescription plan providers cover the medication? Will Janumat become that “answer” for type 2 diabetics, or will it be just out of financial reach for most patients?

via Januvia

Bloomberg

Houston Chronicle

Post from: Blisstree

Federal Approval For New Type 2 Diabetic Medication Janumet